Exchange Traded Concepts, LLC Emergent Bio Solutions Inc. Transaction History

Exchange Traded Concepts, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	BUY	$20.09 - $35.8 $48,095 - $85,705	2,394 Added 15.99%	17,363 $364,000
Q2 2022 Jul 20, 2022	BUY	$27.42 - $43.63 $69,509 - $110,602	2,535 Added 20.39%	14,969 $465,000
Q1 2022 Apr 26, 2022	BUY	$36.48 - $52.22 $453,592 - $649,303	12,434 New	12,434 $511,000
Q3 2021 Oct 18, 2021	SELL	$50.07 - $66.05 $211,946 - $279,589	-4,233 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$56.61 - $80.46 $12,227 - $17,379	216 Added 5.38%	4,233 $267,000
Q1 2021 Apr 20, 2021	SELL	$86.23 - $125.19 $3,535 - $5,132	-41 Reduced 1.01%	4,017 $373,000
Q4 2020 Jan 19, 2021	BUY	$79.17 - $111.47 $36,259 - $51,053	458 Added 12.72%	4,058 $364,000
Q3 2020 Oct 30, 2020	BUY	$81.91 - $134.94 $294,876 - $485,784	3,600 New	3,600 $372,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $515M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.